Royal Bank Of Canada Nanobiotix S.A. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Nanobiotix S.A. stock. As of the latest transaction made, Royal Bank Of Canada holds 129 shares of NBTX stock, worth $499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129Holding current value
$499% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NBTX
# of Institutions
19Shares Held
6.25MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$21.8 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$1.03 Million0.03% of portfolio
-
Black Rock Inc. New York, NY239KShares$924,9600.0% of portfolio
-
Old Mission Capital LLC48.5KShares$187,5940.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$90,1050.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $135M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...